Turkish Airlines Accelerates Operational Efficiencies with MicroStrategy 10TM
MicroStrategy ® Incorporated (Nasdaq: MSTR), a leading worldwide provider of enterprise analytics and mobility software, today announced that Turkish Airlines, an award-winning global airline carrier, has successfully deployed MicroStrategy 10 for greater insight into reservation, ticketing and departure control system (DCS) data, to discover new ways to improve operational performance and minimize travel delays. Established in 1933 with a fleet of five aircraft, Star Alliance member Turkish Airlines is a 4-star airline with a fleet of 329 passenger and cargo aircraft flying to 300 destinations worldwide.
Approximately 5,000 Turkish Airlines employees rely on MicroStrategy’s powerful mobile productivity apps to interact, online or offline, with operational performance data in the palm of their hands. Business users can pull up any one of their mobile apps on their iPads, iPhones and Android mobile devices to write back transactions directly to the database. These transactions include updating passenger reservations, typically as checked-in, boarded, flown or another status as soon as the change occurs. Recently, Turkish Airlines rolled out additional mobile apps for day-to-day airline operations that put transaction services capabilities into action. To hear how Turkish Airlines is leveraging MicroStrategy 10 to enhance operational performance, watch this video.
“With data in the airline industry constantly growing in size and complexity, deploying MicroStrategy 10 has allowed us to organize our library of metadata in one place so we can better understand and act on all our datasets -- Oracle, Hadoop and mainframe -- to identify opportunities that cut costs and minimize travel delays for our passengers,” said Ibrahim Oral Emul, Big Data and Business Intelligence Manager at Turkish Airlines. “We also leveraged the MicroStrategy platform to create a native mobile experience. Our users rely on MicroStrategy Mobile’s unique capabilities to interact with our travel data so we can improve customer satisfaction. MicroStrategy has become a crucial asset for the Turkish Airlines team to accelerate smart decision-making.”
“MicroStrategy recognizes that quality and speed of decision-making can make or break an organization’s ability to execute key decisions better and faster than the competition,” said Michael J. Saylor, CEO, MicroStrategy Incorporated. “We are excited to see the MicroStrategy platform have such a broad impact on Turkish Airlines. Not only has it accelerated how their user community reacts to data to make impactful decisions, but it has also introduced new ways for them to rethink and enhance the passenger experience.”
To learn how organizations can deploy highly impactful mobile apps that can be invaluable to their employees, partners, and customers, download the What Makes an Enterprise Mobile App Great whitepaper today.
About Turkish Airlines
Established in 1933 with a fleet of five aircraft, Star Alliance member Turkish Airlines is a 4-star airline today with a fleet of 329 (passenger and cargo) aircraft flying to 300 destinations worldwide with 251 international and 49 domestic. According to the 2017 Skytrax survey, already having a six-consecutive years of “Best Airline in Europe” award between 2011 and 2016, Turkish Airlines has now been chosen as the "Best Airline in Southern Europe" for the ninth consecutive time. Having won the "Best Economy Class Onboard Catering" award in 2010, Turkish Airlines has been awarded the World’s "Best Business Class Onboard Catering” in 2013, 2014, 2016 and 2017. After winning the “World’s Best Business Class Lounge” award in 2015 and 2017, the global carrier also picked up the World’s “Best Business Class Lounge Dining” award for the third consecutive year according to this year’s survey results. More information about Turkish Airlines can be found on its official website www.turkishairlines.com or its social media accounts on Facebook, Twitter, Youtube, Linkedin, and Instagram.
About MicroStrategy Incorporated
MicroStrategy (Nasdaq: MSTR) is a worldwide leader in enterprise analytics and mobility software. A pioneer in the BI and analytics space, MicroStrategy delivers innovative software that empowers people to make better decisions and transform the way they do business. We provide our enterprise customers with world-class software and expert services so they can deploy unique intelligence applications. To learn more, visit MicroStrategy online, and follow us on Facebook and Twitter.
MicroStrategy, MicroStrategy 10 and MicroStrategy Mobile are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.
Claudia Cahill, 703-270-2207
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 23:37 | Tiedote
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f
Pharnext to Showcase PLEOTHERAPY™ R&D Platform at the 8th Annual Global Orphan Drug Conference19.4.2018 18:45 | Tiedote
Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced that Rodolphe Hajj, Ph.D., the Company’s Chief Pharmacology Officer, will present at the 8th Annual Global Orphan Drug Conference. The presentation will take place as follows: Date & Time: Wednesday April 25th at 4:40 pm EST Title: “Next generation drug repurposing using network pharmacology to develop new therapeutic entities for rare diseases” Venue: Gaylord National Harbor Hotel, Oxon Hill, MD, U.S. Pharnext’s team will also attend the 2018 American Academy of Neurology Annual Meeting as a first-time exhibitor (booth 908). The meeting will take place on April 21-27, 2018 in Los Angeles, CA, U.S. If you are interested in meeting the Pharnext management team during these events, please send an email to firstname.lastname@example.org. About Pharnext Pharne
New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices19.4.2018 18:01 | Tiedote
Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management (PBM).1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419005949/en/ Masimo Radical-7® with SpHb® and RD rainbow SET™ Sensor (Photo: Business Wire) In the study, Prof. Baricchi and colleagues in the Transfusion Medicine Unit, AUSL-IRCCS of Reggio Emilia and at the Department of Medicine and Surgery at the University of Parma, Italy, sought to evaluate the appropriateness of post-operative RBC transfusion over a three-year period (2013-2015), before and after implementation of a patient blood managem
Synteract Repositions Itself with Centers of Therapeutic Development and Unveils Updated Brand Platform19.4.2018 17:06 | Tiedote
Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies bringing new medicines to market, has enhanced its focus. The CRO today announced the creation of therapeutic centers of development that include some of the most progressive in the biopharma industry: oncology, especially leading edge immunotherapy studies, neuro-degenerative disorders, pediatrics, and rare and orphan disease. In addition, Synteract revealed its new market positioning with an updated logo, tagline, and website to reinforce its core capabilities. Synteract’s leadership has been proven in these core development areas, over its nearly 30-year history, through its contributions to more than 240 product approvals. Formal establishment of its new centers of development bring more visibility to Synteract’s longstanding, specialized expertise in these complex areas of clinical research. Synteract CEO Steve Powell says, “By aligning operational excel
Nel ASA: Receives Additional Purchase Order from Nikola19.4.2018 17:00 | Tiedote
Nel ASA (Nel, OSE: NEL) has received a USD 5.5 million purchase order from Nikola Motor Company (Nikola), as part of the previously announced hydrogen stations. “We are very proud to announce that we have received an additional order from Nikola related to the electrolyzer and fueling solution for their prototype trucks. The order marks a strengthening of our partnership and is a recognition of the level of competence our team and hydrogen solutions can offer. We look forward to supplying the demo stations, which will lay the groundwork for the world’s largest, most efficient network of low-cost hydrogen production and fueling sites,” says Jon André Løkke, Chief Executive Officer of Nel. On November 15, 2017, Nikola and Nel announced the exclusive partnership and a purchase order for two so-called demo hydrogen refueling stations for Nikola's fleet of prototype hydrogen trucks. The partnership aims at developing low-cost, renewable hydrogen production and fueling sites for the potentia
Voith and Franka Emika Form a Strategic Partnership19.4.2018 16:39 | Tiedote
The technology company Voith and the Munich-based robotics company Franka Emika have entered into a strategic partnership. Part of the strategic partnership is the establishment of a new joint venture called Voith Robotics – A Voith and Franka Emika Company. The company, with headquarters in Munich, is to become a global system supplier for robot-assisted automation in the digital age. Voith Robotics will offer self-teaching lightweight robots made by Franka Emika, along with software solutions, apps, services and process consulting, to customers in various industries and markets throughout the world. As part of the strategic partnership Voith will also have a direct stake in Franka Emika, thus emphasizing the long-term and strategic commitment by the two companies to cooperation. Martin Scherrer, formerly a member of the Board of Management of Voith Paper, will be the new chief executive officer of Voith Robotics, which is to be managed by Voith. The still very young market for collab
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme